Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.
Chau J, Yadav M, Liu B, Furqan M, Dai Q, Shahi S, Gupta A, Mercer KN, Eastman E, Hejleh TA, Chan C, Weiner GJ, Cherwin C, Lee STM, Zhong C, Mangalam A, Zhang J.
Chau J, et al. Among authors: zhang j.
BMC Cancer. 2021 Jul 13;21(1):808. doi: 10.1186/s12885-021-08530-z.
BMC Cancer. 2021.
PMID: 34256732
Free PMC article.